Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Profiling and Matched Therapy for Recurrent or Metastatic Salivary Gland Neoplasms

NCT02069730 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02069730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02069730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Profiling and Matched Therapy for Recurrent or Metastatic Salivary Gland Neoplasms
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
June 30, 2023
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced, metastatic, recurrent, salivary gland cancer